Wave Life Sciences Ltd 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 27.36, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the first quarter 2026. Average receivable collection period, for the Wave Life Sciences Ltd in Mar 31 2026 quarter, has decreased to 13 days, compared to 20 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 30 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 184 to 308.

What is Receivable Turnover Ratio?
What is Wave Life Sciences Ltd Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

WVE Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	-	-10.27 %	-	25.35 %	-
Y / Y Revenue Change	316.85 %	-59.86 %	-	-55.82 %	-26.82 %
Receivable Turnover Ratio (TTM)	27.36	18.34	33.51	123.65	154.78
WVE's Total Ranking	# 308	# 184	# 1650	# 2430	#
Accounts Receivable average collection period days	13	20	11	3	2
Seq. Receivable Change	-	-87.24 %	518.43 %	-	-
Seq. Revenue Change	13.76 %	341.9 %	-12.54 %	-5.19 %	-89.04 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 10
Healthcare Sector	# 31
Overall Market	# 308

Receivable Turnover Ratio Statistics
High	Average	Low
159.74	23.31	0.65
(Dec 31 2024)		(Sep 30 2020)

WVE Company Profile • Back to WVE Efficiency Comparisons • Compare WVE Receivables Turnover Ratio to its Competitors

Financial Statements
Wave Life Sciences Ltd 's Accounts Receivable	$ 0 Millions	Visit WVE's Balance sheet
Wave Life Sciences Ltd 's Sales TTM	$ 88 Millions	Visit WVE's Income Statement
Sources of WVE's Revenues		Visit WVE's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
WVE's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
WVE's Growth Rates	WVE's Roa	WVE's Inventory Turnover Ratio	WVE's Dividend Comparisons
WVE's Profitability Ratios	WVE's Roi	WVE's Asset Turnover Ratio	WVE's Dividend Growth
WVE's Valuation Ratios	WVE's Roe	WVE's Financial Strength Ratios	WVE's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Mar 31 2026

Receivable at quarter ending Mar 31 2026

Date modified: 2026-08-29T17:33:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.